Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study

• Book ID: 116191981
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 242 KB
• Volume: 159
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2009.11.025